Skip to main content

A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects with Attention-Deficit Hyperactivity Disorder (CEES ADHD)

Clinical Trial Grant
Duke Scholars

Administered By

Psychiatry & Behavioral Sciences

Awarded By

Ironshore Pharmaceuticals & Development, Inc

Start Date

June 15, 2014

End Date

April 20, 2015
 

Administered By

Psychiatry & Behavioral Sciences

Awarded By

Ironshore Pharmaceuticals & Development, Inc

Start Date

June 15, 2014

End Date

April 20, 2015